Search Results - Caleb Alexander

Refine Results
  1. 1

    COVID-19 unemployment and access to statin medications in the United States by Manuel Hermosilla, Caleb Alexander, Caleb Alexander, Dan Polsky, Dan Polsky

    Published in Frontiers in Public Health (2023-03-01)
    Get full text
    Article


  2. 2

    Comparative effectiveness of biologics and targeted therapies for psoriatic arthritis by Jeffrey R Curtis, G Caleb Alexander, Jiajun Wen, Hanzhe Zhang

    Published in RMD Open (2021-03-01)
    Get full text
    Article


  3. 3

    Promotion of prescription drugs to consumers and providers, 2001-2010. by Rachel Kornfield, Julie Donohue, Ernst R Berndt, G Caleb Alexander

    Published in PLoS ONE (2013-01-01)
    Get full text
    Article


  4. 4

    Comparative safety and effectiveness of apixaban and rivaroxaban for treatment of cancer-associated venous thromboembolism: A retrospective cohort study. by Jingjing Sun, Hemalkumar B Mehta, Jodi B Segal, G Caleb Alexander

    Published in PLoS Medicine (2025-09-01)
    Get full text
    Article


  5. 5

    Use of non-insulin diabetes medicines after insulin initiation: A retrospective cohort study. by Yunwen Xu, Scott J Pilla, G Caleb Alexander, Irene B Murimi

    Published in PLoS ONE (2019-01-01)
    Get full text
    Article


  6. 6

    Branded prescription drug spending: a framework to evaluate policy options by Jeromie Ballreich, G. Caleb Alexander, Mariana Socal, Taruja Karmarkar, Gerard Anderson

    Get full text
    Article


  7. 7

    Changes in medical use of central nervous system stimulants among US adults, 2013 and 2018: a cross-sectional study by G Caleb Alexander, Thomas J Moore, Stefan P Kruszewski, Phillip W Wirtz

    Published in BMJ Open (2021-08-01)
    Get full text
    Article


  8. 8

    Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysis by G Caleb Alexander, Hemalkumar B Mehta, Thomas J Moore, Jodi B Segal

    Published in BMJ Open (2020-06-01)
    Get full text
    Article


  9. 9

    Assessment of the U.S. Food and Drug Administration's risk evaluation and mitigation strategy (REMS) for prasugrel (EFFIENT): A narrative review by Thomas Metkus, Jill Curran, Shanshan Lin, Dima M. Qato, G. Caleb Alexander

    Published in American Heart Journal Plus (2024-02-01)
    Get full text
    Article


  10. 10

    Medical use and combination drug therapy among US adult users of central nervous system stimulants: a cross-sectional analysis by G Caleb Alexander, Thomas J Moore, Phillip W Wirtz, Jill N Curran

    Published in BMJ Open (2023-04-01)
    Get full text
    Article


  11. 11

    Healthcare costs and utilization associated with high-risk prescription opioid use: a retrospective cohort study by Hsien-Yen Chang, Hadi Kharrazi, Dave Bodycombe, Jonathan P. Weiner, G. Caleb Alexander

    Published in BMC Medicine (2018-05-01)
    Get full text
    Article


  12. 12

    Efficacy and safety of biosimilar insulins compared to their reference products: A systematic review. by Carolyn Tieu, Eleanor J Lucas, Mindi DePaola, Lori Rosman, G Caleb Alexander

    Published in PLoS ONE (2018-01-01)
    Get full text
    Article


  13. 13

    Impact of Race on Classification of Atherosclerotic Risk Using a National Cardiovascular Risk Prediction Tool by Jarett R. Beaudoin, MD, MPH, Jill Curran, MS, G. Caleb Alexander, MD, MS

    Published in AJPM Focus (2024-04-01)
    Get full text
    Article


  14. 14

    Dipeptidyl peptidase-4 inhibitors and cardiovascular events in patients with type 2 diabetes, without cardiovascular or renal disease. by Sheriza N Baksh, Jodi B Segal, Mara McAdams-DeMarco, Rita R Kalyani, G Caleb Alexander, Stephan Ehrhardt

    Published in PLoS ONE (2020-01-01)
    Get full text
    Article


  15. 15

    National Trends in Use of Sodium‐Glucose Cotransporter‐2 Inhibitors and Glucagon‐like Peptide‐1 Receptor Agonists by Cardiologists and Other Specialties, 2015 to 2020 by Rishav Adhikari, Kunal Jha, Zeina Dardari, James Heyward, Roger S. Blumenthal, Robert H. Eckel, G. Caleb Alexander, Michael J. Blaha

    Get full text
    Article


  16. 16

    High-dose opioid utilization and mortality among individuals initiating hemodialysis by Matthew Daubresse, G. Caleb Alexander, Deidra C. Crews, Dorry L. Segev, Krista Lentine, Mara A. McAdams-DeMarco

    Published in BMC Nephrology (2021-02-01)
    Get full text
    Article


  17. 17

    Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation by Xiaoxi Yao, Neena S. Abraham, G. Caleb Alexander, William Crown, Victor M. Montori, Lindsey R. Sangaralingham, Bernard J. Gersh, Nilay D. Shah, Peter A. Noseworthy

    Get full text
    Article


  18. 18

    Association between organ damage and mortality in systemic lupus erythematosus: a systematic review and meta-analysis by Xia Wang, G Caleb Alexander, Irene B Murimi-Worstell, Dora H Lin, Henk Nab, Hong J Kan, Oluwadamilola Onasanya, Jonothan C Tierce, Barnabas Desta, Edward R Hammond

    Published in BMJ Open (2020-05-01)
    Get full text
    Article


  19. 19

    Drug–drug interaction between dexamethasone and direct-acting oral anticoagulants: a nested case–control study in the National COVID Cohort Collaborative (N3C) by Charles E Leonard, Ainhoa Gomez-Lumbreras, Daniel C Malone, Kathleen M Andersen, G Caleb Alexander, Olga V Kravchenko, Richard D Boyce, Paul T Kocis, Lorenzo Villa Zapata, Malinda Tan, Hemalkumar Mehta

    Published in BMJ Open (2022-12-01)
    Get full text
    Article


  20. 20

    Clinical trial registration and reporting: a survey of academic organizations in the United States by Evan Mayo-Wilson, James Heyward, Anthony Keyes, Jesse Reynolds, Sarah White, Nidhi Atri, G. Caleb Alexander, Audrey Omar, Daniel E. Ford, on behalf of the National Clinical Trials Registration and Results Reporting Taskforce Survey Subcommittee

    Published in BMC Medicine (2018-05-01)
    Get full text
    Article


Search Tools: